Table 4.
Amount of vigorous and light-to-moderate physical activity and time spent in vigorous, light-to-moderate, and sedentary physical activity in inactive subjects.
| CP (n = 13) | PL (n = 11) | |||||||
|---|---|---|---|---|---|---|---|---|
| BL | 4w | 8w | 12w | BL | 4w | 8w | 12w | |
| Amount of VPA, METs×hour/week | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.1 ± 0.2 | 0.0 ± 0.0 | 0.0 ± 0.1 | 0.2 ± 0.3 | 1.3 ± 4.1 | 4.2 ± 12.8 |
| Time of VPA, min/day | 0.0 ± 0.1 | 0.0 ± 0.0 | 0.1 ± 0.2 | 0.0 ± 0.0 | 0.1 ± 0.1 | 0.3 ± 0.4 | 1.8 ± 5.4 | 5.2 ± 16.1 |
| Amount of LMPA, METs×hour/week | 84.5 ± 17.2 | 95.4 ± 21.1 | 98.8 ± 22.8 | 99.2 ± 24.9* | 99.7 ± 23.3 | 103.8 ± 23.5 | 105.2 ± 20.8 | 103.8 ± 21.9 |
| Time of LMPA, min/day | 329.0 ± 63.0 | 374.8 ± 72.5 | 386.6 ± 78.1 * | 389.4 ± 84.2 ** | 385.6 ± 94.2 | 395.6 ± 93.6 | 395.3 ± 84.8 | 391.0 ± 86.3 |
| Sedentary time, min/day | 558.9 ± 62.9 | 532.9 ± 81.8 | 559.2 ± 93.6 | 576.9 ± 90.7 | 524.4 ± 57.7 | 541.3 ± 57.8 | 544.5 ± 75.2 | 533.3 ± 89.0 |
| Energy expenditure in physical activity, kcal/day | 481.2 ± 96.3 | 542.7 ± 127.1 * | 560.9 ± 129.5 ** | 562.5 ± 145.5 *** | 536.8 ± 112.2 | 565.7 ± 109.7 | 586.4 ± 101.7 | 598.6 ± 127.6 |
Abbreviations: CP, capsinoids group; PL, placebo group; BL, baseline; 4 w, 4th week; 8 w, 8th week; 12 w, 12th week; VPA, vigorous physical activity. Significantly larger change than PL in linear mixed model repeated ANOVA (* p < 0.05; ** p < 0.01; *** p < 0.001).